RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine

PL Hervé, C Deloizy, D Descamps… - … , Biology and Medicine, 2017 - Elsevier
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in
children, yet no vaccine is available. The sole licensed preventive treatment against RSV is …
被引用次数：32 相关文章

RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine

PL Hervé, C Deloizy, D Descamps, MA Rameix Welti… - 2017 - agris.fao.org
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in
children, yet no vaccine is available. The sole licensed preventive treatment against RSV is …
[HTML] nih.gov

[HTML][HTML] RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine

PL Hervé, C Deloizy, D Descamps… - … biology, and medicine, 2017 - ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in
children, yet no vaccine is available. The sole licensed preventive treatment against RSV is …

RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine

PL Hervé, C Deloizy, D Descamps… - Nanomedicine …, 2017 - pubmed.ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in
children, yet no vaccine is available. The sole licensed preventive treatment against RSV is …

RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine.

PL Hervé, C Deloizy, D Descamps… - Nanomedicine …, 2016 - europepmc.org
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in
children, yet no vaccine is available. The sole licensed preventive treatment against RSV is …

RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine

PL Hervé, C Deloizy, D Descamps… - … , Biology and Medicine, 2017 - infona.pl
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in
children, yet no vaccine is available. The sole licensed preventive treatment against RSV is …

RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine.

PL Hervé, C Deloizy, D Descamps… - Nanomedicine …, 2016 - europepmc.org
Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in
children, yet no vaccine is available. The sole licensed preventive treatment against RSV is …